Influence of Drugs on Vitamin D and Calcium Metabolism

Overview

Journal Dermatoendocrinol

Specialty Endocrinology

Date 2012 Aug 29

PMID 22928072

Citations 65

Authors

Uwe Grober

Klaus Kisters

Affiliations

Soon will be listed here.

Abstract

In the past, interactions between drugs and vitamin D have received only little or no attention in the health care practices. However, since more and more drugs are used for the treatment of patients, this topic is increasingly relevant. Several drugs can interfere with the vitamin D and bone metabolism. Drugs that activate the pregnane X receptor can disrupt vitamin D metabolism and vitamin D function. Beside this, the medication oriented supplementation of vitamin D can ameliorate the pharmacologic action of some drugs, such as bisphosphonates, cytostatics and statins.

Citing Articles

Vitamin D Deficiency-A Public Health Issue in Children.

Herdea A, Marie H, Ionescu A, Sandu D, Pribeagu S, Ulici A Children (Basel). 2024; 11(9).

PMID: 39334594 PMC: 11429966. DOI: 10.3390/children11091061.

Role of vitamin D in COVID-19 and other viral infections.

Engin M, Ozdemir O World J Virol. 2024; 13(3):95349.

PMID: 39323448 PMC: 11401007. DOI: 10.5501/wjv.v13.i3.95349.

Is vitamin D associated with disease activity in patients with axial or peripheral spondyloarthritis? A real-life study.

Mbuyi M, Kavangh H, Grubisic F, Doko Vajdic I, Grazio S Rheumatol Int. 2024; 44(10):2079-2087.

PMID: 39180527 DOI: 10.1007/s00296-024-05674-6.

The Role of Water-Soluble Vitamins and Vitamin D in Prevention and Treatment of Depression and Seasonal Affective Disorder in Adults.

Jahan-Mihan A, Stevens P, Medero-Alfonso S, Brace G, Overby L, Berg K Nutrients. 2024; 16(12).

PMID: 38931257 PMC: 11206829. DOI: 10.3390/nu16121902.

Vitamin D Deficiency in Professional Football Players during Competitive Season of Italian First Division (Serie A).

Perrone M, Pieri M, Caminiti G, Ali W, Bernardini S, Parisi A Sports (Basel). 2024; 12(6).

PMID: 38921847 PMC: 11209379. DOI: 10.3390/sports12060153.

References

DENT C, Richens A, Rowe D, Stamp T . Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J. 1970; 4(5727):69-72. PMC: 1819593. DOI: 10.1136/bmj.4.5727.69. View

Servitja S, Nogues X, Prieto-Alhambra D, Martinez-Garcia M, Garrigos L, Pena M . Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer. Breast. 2011; 21(1):95-101. DOI: 10.1016/j.breast.2011.09.001. View

Holick M . Stay tuned to PXR: an orphan actor that may not be D-structive only to bone. J Clin Invest. 2005; 115(1):32-4. PMC: 539210. DOI: 10.1172/JCI23995. View

Perez-Castrillon J, Abad Manteca L, Vega G, Montes J, de Luis D, Duenas Laita A . Vitamin d levels and lipid response to atorvastatin. Int J Endocrinol. 2009; 2010:320721. PMC: 2779456. DOI: 10.1155/2010/320721. View

Lacativa P, de Farias M . Osteoporosis and inflammation. Arq Bras Endocrinol Metabol. 2010; 54(2):123-32. DOI: 10.1590/s0004-27302010000200007. View

Pascussi J, Robert A, Nguyen M, Walrant-Debray O, Garabedian M, Martin P . Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest. 2005; 115(1):177-86. PMC: 539191. DOI: 10.1172/JCI21867. View

Martineau A, Timms P, Bothamley G, Hanifa Y, Islam K, Claxton A . High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2011; 377(9761):242-50. PMC: 4176755. DOI: 10.1016/S0140-6736(10)61889-2. View

Ahmed W, Khan N, Glueck C, Pandey S, Wang P, Goldenberg N . Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res. 2008; 153(1):11-6. DOI: 10.1016/j.trsl.2008.11.002. View

Li Y, Kong J, Wei M, Chen Z, Liu S, Cao L . 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110(2):229-38. PMC: 151055. DOI: 10.1172/JCI15219. View

10.

Brehm J, Schuemann B, Fuhlbrigge A, Hollis B, Strunk R, Zeiger R . Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010; 126(1):52-8.e5. PMC: 2902692. DOI: 10.1016/j.jaci.2010.03.043. View

11.

Allen A, Kelly S, Basdeo S, Kinsella K, Mulready K, Mills K . A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers. Mult Scler. 2012; 18(12):1797-800. DOI: 10.1177/1352458512442992. View

12.

Lakatos P, Nagy Z, Kiss L, Horvath C, Takacs I, Foldes J . Prevention of corticosteroid-induced osteoporosis by alfacalcidol. Z Rheumatol. 2000; 59 Suppl 1:48-52. DOI: 10.1007/s003930070040. View

13.

Ginde A, Mansbach J, Camargo Jr C . Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009; 169(4):384-90. PMC: 3447082. DOI: 10.1001/archinternmed.2008.560. View

14.

Buchanan J, Santen R, Cauffman S, Cavaliere A, Greer R, Demers L . The effect of endogenous estrogen fluctuation on metabolism of 25-hydroxyvitamin D. Calcif Tissue Int. 1986; 39(3):139-44. DOI: 10.1007/BF02555109. View

15.

Bartl R, Bartl C, Gradinger R . [Drug-induced osteopathies. Drugs, pathogenesis, forms, diagnosis, prevention and therapy]. Z Rheumatol. 2010; 69(2):135-50. DOI: 10.1007/s00393-010-0605-5. View

16.

Goodwin P, Ennis M, Pritchard K, Koo J, Hood N . Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol. 2009; 27(23):3757-63. DOI: 10.1200/JCO.2008.20.0725. View

17.

Khan Q, Kimler B, Fabian C . The relationship between vitamin D and breast cancer incidence and natural history. Curr Oncol Rep. 2010; 12(2):136-42. DOI: 10.1007/s11912-010-0081-8. View

18.

van Staa T, Abenhaim L, Cooper C, Zhang B, Leufkens H . The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf. 2008; 9(5):359-66. DOI: 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E. View

19.

Smith I, Dowsett M . Aromatase inhibitors in breast cancer. N Engl J Med. 2003; 348(24):2431-42. DOI: 10.1056/NEJMra023246. View

20.

Ardine M, Generali D, Donadio M, Bonardi S, Scoletta M, Vandone A . Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?. Ann Oncol. 2006; 17(8):1336-7. DOI: 10.1093/annonc/mdl045. View